Arruda et al The Chemical Abstract, vol. 106, p. 90, 1987 Abst. No. 61505x. |
Kiess et al, The Chemical Abstract, vol. 99, p. 102 1983, abst. No. 82789u. |
Nagy, et al., "Immunomodulation by Bromocriptine", Immunopharmacology, 6:231-243 (1983). |
Palestine, et al., "Bromocriptine and Low Dose Cyclosporine in the Treatment of Experimental Autoimmune Uveitis in the Rat", J. Clin. Invest., 79:1078-1081 (1987). |
McCallum, et al., "Metoclopramide Stimulated Prolactin Secretion in Man", Jce of M, 42:1148-1152 (1976). |
Hiestand, et al., "Prolactin as a modulator of lymphocyte responsivesness provides a possible mechanism of action for cyclosporine", Proc. Nat Acadmey of Science, 83:2599-2603 (1986). |
Millard, et al., "Cysteamine Induced Depletion of Both Immunological and Biological Prolactin Activity in the Anterior Pituitary and Blood of the Rat", Endocrinology, 113:2161-2167 (1983). |
Yamauchi, et al., "effect of Metoclopramide on rat Prolactin Secretin In Vivo", Life Sceinces, 20:1581-1583 (1977). |
Bernton, et al., "Antibody to Mouse Prolactin Inhibits Murine Lymphocyte Responses to T-Cell Growth Factors (TCGF)", presented at the 11th Inter. Res. Congress & 24th Nat. 1. Reticuloendotheial Society, Oct. 17-21, 1987. |
Bernton, et al., "Inhibition of Macrophage In Vivo Activation by Pharmacologic Blockade of Prolactin Release", Leukocytes and Host Defense, pp. 213-219 (1986). |
Mancini, et al., "Effect of Sulpiride on Serum Prolactin Levels in Humans", J. Clin. Endoc. Metal., 48:181-183 (1976). |
Connell, et al., "Effect of Low-Dose Dopamine Infusion on Basal and Stimulated TSH and Prolactin Concentrations, in Man", Clin. Endoc, 23:185-192 (1985). |
Russell, et al., "Prolactin Receptors on Human Lymphocytes and Their Modulation by Cyclosporine", Biochem. Biophys. Res. Comm., 121:899-906 (1984). |
Russell, et al., "Prolactin Receptors on Rat Lymphoid Tissues and on a Human T-and B-Lymphocytes: Antagonism of Prolactin Binding by Cyclosporine", Prolactin, Basic and Clinical Correlates, pp. 375-384 (1985). |
Gahl, et al., "Blunted Prolactin Response to Thyrotropin-Releasing Hormone Stimulation in Cystinotic Children Receiving Cysteamine", J. Clin. Endocr. Metal., 60:793-796 (1985). |
Bernton, "Prolactin and Immune Host Defenses", PNEI Perspectives, vol. 2, No. 1, 1989, pp. 21-29. |
Hartman, et al., "Inhibition of Lymphocyte Proliferation by Anti-bodies to Prolactin", The FASEB Journal vol. 3, pp. 2194-2202 (Aug. 1989). |
Dave, et al., "Prolactin binding a capacity, prostaglandin systhesis and fluidity of murine hepatic membranes are modified during pregnancy and lactation", J. Endocr., pp. 99-106. |
Russell, et al., "Prolactin-dependent Mitogenesis in Nb 2 Node Lymphoma Cells: Effects of Immuno-Suppressive Cyclopeptides", J. of Immunology, vol. 138, pp. 276-284, (Jan. 1, 1987). |
Boutin, et al., "Cloning an Expression of the Rat Prolactin Receptor a Number of the Growth Hormone/Prolactin Receptor Gene Family", Cell Press, vol. 53, pp. 69-77, (Apr. 1988). |
Boutin, et al., "Long Form of Prolactin Receptor In Human Hepatoma and Breast Cancer Cell", Molecular Endocr. pp. 1455-1461 (1989). |
Bryant, et al., "Cysteamine Produces Dose-Related Bidirectional Immunomondulatory Effects in Mice", Journal of Pharm. and Exper. Therap., vol. 249, No. 2, pp. 424-429 (1989). |
Millard, et al., "Cysteamine-induced depletion of somatostatin and prolactin", Federation Proc. 44:pp. 2546-2550 (1985). |
Bryant, et al., "Immunsuppression Effects of Chronic Morphine Treatment of Rats", Life Sciences, vol. 41 pp. 1731-1738. |
Huseby, et al., "Ectopic Pituitary Grafts in Mice: Hormone Levels, Effects on Fertility, and the Development of Adenomyosis Ulterv, Prolactinomas, and Mannary Carcinomas", Endocrinology, 116:1440-1448 (1985). |
Bernton, et al., "Suppression of Macrophase Activation and T-Lymphocyte Function in Hypoprolactinemic Mice", Science vol. 4, pp. 401-404 (Jan. 1988). |
Hellhammer, et al., "Neurobiological Approaches to Human Disease", Library of Congress pp. 289-300 (1988). |
Bernton, et al., "Pharmologic Manipulation of Pituitary Prolactin Secretion Modifies Lymphocyte Function in Mice". |
Bernton, et al., "Suppression of Prolactin by Drugs: An IATrogenic Cause of Immunosuppression". |
Jaroff, Time "Stop That Germ", pp. 56-64, May 25, 1988. |
Cooke et al., "Human Prolactin: DCNA Structural Analysis and Evolutionary Comparison", The Journal of Biological Chemistry, vol . 256, No. 8, pp. 4007-4016 (Apr. 25, 1981). |
Nicoll et al., "Structural Features of Prolactins and Growth Hormones that can be Related to Their Biological Properties", Endocrin Reviews, vol. 7 No. 2, pp. 169-203 (1986). |
Cunningham et al., "Engineering Human Prolactin to Bind to the Human Growth Receptor," Science Reports, vol. 247, pp. 1461-1464 (Mar. 23, 1990). |
Cunningham et al., "Zinc Mediation of the Binding of Human Growth Hormone to the Human Prolactin Receptor," Science Reports, vol. 250, pp. 1709-1712 (Dec. 21, 1990). |
Rozakis-Adcock et al., "Mutational Analysis of the Ligand-Binding Domain of the Prolactin Receptor", The Journal of Biological Chemistry, vol. 266, No. 25, pp. 16472-16477 (Sep. 5, 1991). |
Paris et al., "Bacterial Production and Purification of Recombinant Human Prolactin", Biotecnol. Appl. Biochem., vol. 12, No. 4, pp. 436-449 (1990). |